Harrow Health (HROW) stock price, revenue, and financials

Harrow Health market cap is $147.7 m, and annual revenue was $51.17 m in FY 2019

$147.7 M

HROW Mkt cap, 22-Sept-2020

$8.1 M

Harrow Health Revenue Q2, 2020
Harrow Health Gross profit (Q2, 2020)4.9 M
Harrow Health Gross profit margin (Q2, 2020), %60.2%
Harrow Health Net income (Q2, 2020)-260 K
Harrow Health EBIT (Q2, 2020)-3.2 M
Harrow Health Cash, 30-Jun-20204.1 M
Harrow Health EV167.9 M

Harrow Health Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

100.0k10.0k1.7m9.7m19.9m26.8m41.4m51.2m

Revenue growth, %

485%105%

Cost of goods sold

16.5m16.7m

Gross profit

24.9m34.4m

Gross profit Margin, %

60%67%

Sales and marketing expense

2.4m6.5m7.4m7.1m

R&D expense

111.6k1.3m1.6m236.7k332.0k739.0k413.0k825.0k2.1m

General and administrative expense

827.7k3.0m6.1m8.1m12.5m17.6m18.0m29.2m33.1m

Operating expense total

939.2k4.3m7.7m10.7m19.3m26.0m25.4m30.1m39.2m

EBIT

(939.2k)(4.2m)(7.7m)(10.1m)(14.8m)(15.9m)(12.2m)(5.2m)(4.8m)

EBIT margin, %

(4179%)(76869%)(611%)(153%)(80%)(45%)(13%)(9%)

Interest expense

75.0k24.7k28.6k1.1m2.8m3.0m2.7m2.5m

Interest income

15.4k43.8k32.4k

Pre tax profit

(12.9m)14.6m(125.0k)

Income tax expense

2.8k5.0k111.0k(935.0k)6.0k8.0k

Net Income

(953.9k)(5.4m)(7.6m)(10.1m)(15.9m)(19.1m)(12.0m)14.6m(125.0k)

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

100.0k2.5k2.5k2.5k1.4k667.7k441.0k1.6m2.0m2.7m4.4m4.9m4.9m6.1m6.9m6.5m8.9m10.4m10.7m12.3m13.5m12.8m11.8m8.1m

Cost of goods sold

4.2m4.2m3.9m5.2m4.1m3.6m3.2m

Gross profit

6.2m6.5m8.4m8.3m8.7m8.2m4.9m

Gross profit Margin, %

60%61%68%61%68%69%60%

Sales and marketing expense

469.2k636.6k1.0m1.6m1.8m1.9m2.3m1.8m2.4m2.0m1.3m

R&D expense

24.3k143.0k133.6k303.7k455.1k677.3k469.5k60.2k35.6k70.1k181.0k25.0k93.0k46.0k76.0k16.0k160.0k101.0k63.0k87.0k72.0k233.0k405.0k810.0k444.0k403.0k749.0k

General and administrative expense

121.4k66.5k309.0k984.7k946.4k1.0m1.6m1.6m2.3m2.3m2.0m2.5m2.7m3.1m3.9m4.4m5.0m4.4m4.5m4.5m6.5m6.8m7.0m8.5m8.2m8.6m8.4m7.0m

Operating expense total

145.8k66.5k451.9k1.1m1.3m1.5m2.2m2.1m2.3m2.8m2.7m3.7m4.4m5.0m5.9m6.7m7.1m7.0m6.6m5.8m6.6m6.9m7.2m8.9m9.1m13.1m8.8m8.1m

EBIT

(145.8k)(66.5k)(351.9k)(1.1m)(1.3m)(1.5m)(2.2m)(2.1m)(2.3m)(2.6m)(2.5m)(3.1m)(3.5m)(3.5m)(3.8m)(4.0m)(4.6m)(4.2m)(3.0m)(2.8m)(1.8m)(624.0k)(649.0k)(556.0k)(767.0k)(4.4m)(628.0k)(3.2m)

EBIT margin, %

(352%)(58902%)(89240%)(83596%)(165636%)(390%)(557%)(199%)(177%)(132%)(86%)(82%)(95%)(69%)(44%)(43%)(20%)(6%)(6%)(5%)(6%)(34%)(5%)(40%)

Interest expense

18.7k18.9k21.1k3.6k6.5k7.0k249.0k423.0k629.0k631.0k732.0k788.0k767.0k793.0k663.0k671.0k705.0k603.0k716.0k620.0k560.0k505.0k

Interest income

5.6k4.2k7.1k12.9k12.4k10.3k8.7k7.5k

Pre tax profit

(5.0m)1.5m(5.7m)(3.5m)2.5m(2.5m)(12.9m)(260.0k)

Income tax expense

(28.0k)(28.0k)(28.0k)

Net Income

(164.5k)(85.4k)(1.4m)(1.3m)(1.2m)(1.5m)(2.2m)(2.1m)(2.3m)(2.6m)(2.5m)(3.1m)(3.7m)(4.0m)(4.5m)(4.6m)(3.8m)(5.0m)1.5m(5.7m)(3.5m)2.5m(2.5m)11.4m(2.4m)(11.5m)(12.9m)(260.0k)

Harrow Health Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

146.2k10.0m15.6m8.2m2.7m8.9m4.0m6.8m4.9m

Accounts Receivable

81.3k840.0k2.9m1.5m1.9m2.0m

Prepaid Expenses

14.8k61.6k105.1k240.4k786.0k714.0k837.0k1.3m

Inventories

372.7k1.4m1.8m2.2m1.8m3.3m

Current Assets

161.0k10.7m15.7m9.1m5.9m14.8m8.8m32.8m36.8m

PP&E

12.5k26.9k243.4k2.7m7.3m6.2m6.4m5.4m

Goodwill

331.6k2.5m2.2m2.2m2.2m332.0k

Total Assets

161.0k10.7m15.8m10.2m14.1m27.2m23.9m49.5m59.1m

Accounts Payable

218.6k286.7k311.9k786.7k3.4m3.5m3.9m6.3m7.7m

Short-term debt

24.1k21.0k598.0k3.2m2.4m

Current Liabilities

1.9m709.6k650.6k1.6m5.4m9.9m5.8m11.9m12.3m

Long-term debt

19.0k1.0k14.7m12.0m18.6m

Total Debt

43.1k21.0k15.3m15.2m21.0m

Total Liabilities

1.9m2.1m15.5m20.8m21.3m24.7m31.7m

Common Stock

15.9k6.8k9.0k9.3k10.0k21.0k24.0k26.0k

Preferred Stock

Additional Paid-in Capital

16.8m34.1m46.8m50.0m56.4m83.3m91.4m98.9m101.7m

Retained Earnings

31.7m(41.9m)(57.8m)(76.9m)(88.8m)(74.2m)(74.0m)

Total Equity

(1.7m)10.0m15.1m8.2m(1.4m)6.4m2.6m24.8m27.4m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

-0.1 x1.1 x1 x1.3 x-10.2 x4.2 x9.1 x2 x2.2 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

5.6k2.2k146.7k7.7m11.0m19.0m18.0m16.8m14.2m12.1m10.4m2.9m10.1m6.6m11.8m5.4m2.4m7.4m4.2m3.9m2.9m4.2m6.3m4.3m4.2m3.6m4.1m4.1m

Accounts Receivable

1.4k81.1k68.3k436.0k579.0k701.0k943.0k1.9m2.2m3.0m2.9m2.6m1.5m1.4m1.7m2.2m2.2m2.8m2.0m2.0m

Prepaid Expenses

70.8k74.4k63.8k45.9k76.1k204.5k340.5k506.1k123.7k324.2k335.7k413.0k436.0k685.0k779.0k489.0k1.2m925.0k786.0k943.0k851.0k982.0k1.1m1.7m1.4m1.4m1.3m1.3m

Inventories

172.8k351.2k711.0k793.0k1.3m1.2m1.4m1.9m2.0m1.8m2.4m2.0m2.2m2.5m2.4m2.7m2.4m4.0m3.8m

Current Assets

76.3k76.5k210.5k7.9m11.5m19.2m18.4m17.4m14.4m12.8m11.3m4.6m12.0m9.4m14.9m9.4m9.0m13.6m10.4m10.1m7.4m8.7m11.7m38.5m38.1m32.4m25.8m30.4m

PP&E

14.2k14.1k13.2k13.1k15.6k19.5k34.2k75.8k179.1k479.0k601.0k1.1m4.8m7.1m7.3m7.1m6.6m6.4m6.0m6.0m6.1m6.2m5.9m5.2m5.1m5.0m

Goodwill

331.6k331.6k1.1m1.2m1.4m2.5m2.5m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m2.2m332.0k332.0k332.0k

Total Assets

76.3k76.5k224.7k7.9m11.5m19.2m18.4m17.4m14.5m13.9m12.4m9.4m16.9m15.0m25.3m22.0m21.5m25.9m27.6m26.2m21.2m26.3m28.3m66.5m65.2m54.7m46.9m49.5m

Accounts Payable

176.1k178.4k256.7k423.5k594.9k700.8k868.4k725.5k457.1k750.1k804.2k1.1m1.2m1.9m4.3m4.0m3.8m3.9m3.3m4.0m3.9m4.7m5.9m6.1m6.9m8.1m7.5m5.8m

Short-term debt

6.4k23.9k27.0k27.0k27.0k15.0k8.0k434.0k6.7m1.5m562.0k906.0k1.7m2.6m3.1m247.0k1.0m3.2m4.1m

Current Liabilities

1.6m1.6m930.5k491.2k669.8k848.5k1.1m1.1m655.5k1.3m1.6m2.2m2.7m3.7m5.7m5.3m5.8m11.8m5.5m6.1m5.9m8.2m10.4m11.2m9.9m11.4m13.2m13.1m

Long-term debt

10.2k25.1k12.0k8.0k1.0k9.4m11.2m7.2m12.9m14.8m14.4m13.6m12.7m17.5m19.5m18.7m17.8m20.2m

Total Debt

10.2k23.9k27.0k27.0k27.0k15.0k8.0k11.6m13.9m14.3m15.3m15.3m15.3m15.3m20.6m19.8m19.8m21.0m24.2m

Total Liabilities

1.6m1.6m1.8m2.1m3.2m11.6m12.8m16.5m16.4m18.7m20.6m20.0m22.5m21.1m22.6m23.8m29.5m30.2m31.0m31.9m34.1m

Common Stock

15.9k15.9k11.2k29.7k33.9k8.9k9.0k9.0k9.1k9.1k9.2k9.0k10.0k10.0k13.0k13.0k13.0k20.0k20.0k20.0k21.0k21.0k23.0k25.0k25.0k25.0k26.0k26.0k

Preferred Stock

Additional Paid-in Capital

16.5m16.6m19.2m28.8m33.4m44.0m45.0m46.2m47.9m48.7m49.4m51.2m53.9m54.9m71.0m72.5m73.6m87.2m88.0m89.8m92.4m93.5m96.8m99.9m100.3m100.6m102.3m102.9m

Retained Earnings

25.6m29.9m34.1m(36.7m)(39.1m)(45.0m)(48.7m)(52.6m)(62.3m)(66.9m)(70.7m)(81.9m)(80.4m)(86.1m)(92.3m)(89.8m)(92.3m)(62.9m)(65.2m)(76.7m)(86.9m)(87.2m)

Total Equity

(1.5m)(1.6m)(705.8k)7.4m10.8m18.4m17.3m16.3m13.8m12.0m10.3m6.2m5.2m2.2m8.8m5.6m2.8m5.3m7.6m3.7m83.0k3.7m4.5m37.0m35.0m23.7m15.0m15.4m

Debt to Equity Ratio

0 x0 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x0 x

Financial Leverage

-0.1 x0 x-0.3 x1.1 x1.1 x1 x1.1 x1.1 x1 x1.2 x1.2 x1.5 x3.2 x6.7 x2.9 x3.9 x7.6 x4.9 x3.6 x7 x255.4 x7.1 x6.4 x1.8 x1.9 x2.3 x3.1 x3.2 x

Harrow Health Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(596.8k)(682.2k)(1.4m)(2.7m)(3.9m)(1.5m)(3.7m)(5.8m)(2.3m)(4.9m)(7.4m)(3.1m)(6.8m)(10.8m)(4.5m)(9.1m)(13.0m)(5.0m)(3.5m)(9.2m)(3.5m)(991.0k)(3.5m)11.4m8.9m(2.7m)(12.9m)(13.2m)

Depreciation and Amortization

338.0338.0404.01.2k2.1k899.02.1k3.5k2.6k27.8k50.7k126.0k278.0k450.0k174.0k534.0k961.0k435.0k840.0k1.3m459.0k917.0k1.4m452.0k1.1m1.5m493.0k1.0m

Accounts Receivable

1.4k22.7k(9.9k)44.0k(99.0k)(221.0k)(103.0k)(1.1m)(2.2m)(115.0k)65.0k296.0k55.0k169.0k(202.0k)(280.0k)(309.0k)(901.0k)(20.0k)(311.0k)

Inventories

(40.4k)(138.0k)(106.0k)(188.0k)(605.0k)179.0k(29.0k)(490.0k)(203.0k)(404.0k)(946.0k)209.0k33.0k(275.0k)(554.0k)(818.0k)(1.4m)(688.0k)(540.0k)

Accounts Payable

102.4k104.8k38.1k117.2k61.4k65.4k284.0k229.6k145.2k318.1k372.2k104.0k121.0k845.0k996.0k1.6m1.6m364.0k(194.0k)497.0k106.0k885.0k2.2m158.0k830.0k1.7m(337.0k)(2.3m)

Cash From Operating Activities

(285.9k)(316.8k)(334.8k)(617.4k)(1.3m)(1.1m)(2.1m)(3.2m)(1.7m)(3.2m)(5.0m)(2.3m)(5.4m)(7.8m)(2.3m)(5.1m)(9.0m)(4.0m)(6.3m)(8.5m)(965.0k)400.0k723.0k(1.5m)(632.0k)(702.0k)(550.0k)(3.2m)

Purchases of PP&E

(14.6k)(15.3k)(15.3k)(1.4k)(5.2k)(10.5k)(9.9k)(14.8k)(91.9k)(28.0k)(208.0k)(704.0k)(2.4m)(5.7m)(6.5m)(150.0k)(322.0k)(588.0k)(192.0k)(550.0k)(1.1m)(213.0k)(565.0k)(589.0k)(220.0k)(536.0k)

Cash From Investing Activities

(14.6k)(15.3k)(15.3k)(51.4k)(55.2k)(60.5k)(51.2k)(751.1k)(828.4k)(3.0m)(3.2m)(4.3m)(2.4m)(6.0m)(7.1m)(216.0k)(515.0k)(712.0k)(264.0k)(700.0k)(1.3m)(324.0k)(785.0k)(864.0k)(273.0k)(610.0k)

Short-term Borrowings

(601.0k)(750.0k)(750.0k)(750.0k)

Long-term Borrowings

(1.6k)(4.6k)(7.0k)(11.0k)(18.0k)(7.0k)(14.0k)(119.0k)(152.0k)(305.0k)(464.0k)(163.0k)(337.0k)(512.0k)(185.0k)(375.0k)(744.0k)(2.0k)(3.0k)

Cash From Financing Activities

27.5k350.0k8.2m12.1m10.1m10.1m10.1m349.6k482.5k616.7k(5.0k)10.5m10.4m13.9m13.8m15.8m2.7m2.1m4.2m(98.0k)251.0k2.7m(773.0k)(1.2m)(1.6m)(2.0k)3.0m

Net Change in Cash

(285.9k)(289.3k)551.07.6m10.8m8.9m7.9m6.8m(1.4m)(3.5m)(5.2m)(5.3m)1.8m(1.7m)9.1m2.8m(323.0k)(1.5m)(4.7m)(5.0m)(1.3m)(49.0k)2.1m(2.6m)(2.6m)(3.2m)(825.0k)(847.0k)

Interest Paid

1.6k2.6k2.0k68.0k414.0k291.0k616.0k984.0k428.0k901.0k1.0m483.0k1.0m1.0m467.0k1.1m1.5m408.0k408.0k

Income Taxes Paid

1.6k1.6k1.6k800.0800.0800.01.0k1.0k1.0k9.0k9.0k9.0k9.0k2.0k4.0k4.0k8.0k11.0k

Harrow Health Ratios

USDQ2, 2011

Financial Leverage

-0.1 x